Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep1059 | Thyroid (non-cancer) | ECE2016

Hoffmann syndrome: a case report

Barka Ines , Maaroufi Amel , Badr Wafa , Hasni Yosra , Kacem Maha , Chadli Chaieb Molka , Ach Koussay

Background: Hoffmann syndrome is a rare form of hypothyroid myopathy in adults characterized by presence of muscle weakness, stiffness and pseudo-hypertrophy. Here, we report a case of Hoffman syndrome aggravated by statin therapy.Case report: We describe the case of a 60 year old woman with primary hypothyroidism who presented with fatigue, cold intolerance, constipation, exertional breathlessness, progressive proximal muscle weakness and swelling of th...

ea0063p939 | Diabetes, Obesity and Metabolism 3 | ECE2019

Prevalence and predictive factors of advanced fibrosis in type 2 diabetic patient in a majoritally abstinent population of alcohol

Fennoun Halima , El Mansouri Souhaila , Tahiri Mohamed , El Aziz Siham , Haddad Farid , Hliwa Wafaa , Badr Wafa , Chadli Asma

Introduction: Metabolic steatopathy is frequently associated with type 2 diabetes, which may progress to advanced fibrosis. The objectives of this study were to evaluate the prevalence and predictors of the severity of hepatic impairment in this population.Methods: A cross-sectional study involving 281 type 2 diabetic patients followed in the endocrinology department in collaboration with the Hepato-Gastroenterology department of Ibn Rochd University Hos...

ea0063p949 | Diabetes, Obesity and Metabolism 3 | ECE2019

Detection of metabolic hepatic steatosis in type 2 diabetic patient: about 281 cases

Fennoun Halima , Mansouri Souhaila El , Tahiri Mohamed , Aziz Siham El , Haddad Farid , Hliwa Wafaa , Badr Wafa , Chadli Asma

Introduction: Metabolic liver steatosis is frequently associated with type 2 diabetes with an increased risk of progression to advanced fibrosis. Objective of this study was to estimate the prevalence of hepatic steatosis in patients with type 2 diabetes.Methods: A cross-sectional study including 281 type 2 diabetic patients followed at the Department of Endocrinology in collaboration with the Hepato-Gastroenterology Department of Ibn Rochd University Ho...

ea0063p953 | Diabetes, Obesity and Metabolism 3 | ECE2019

Hepatic steatosis and cardiovascular risk in diabetic patient type 2

Fennoun Halima , Mansouri Souhaila El , Tahiri Mohamed , Aziz Siham El , Haddad Farid , Hliwa Wafaa , Badr Wafa , Chadli Asma

Introduction: Metabolic hepatic steatosis is a common condition in patients with type 2 diabetes, increasing the risk of cardiovascular morbidity and mortality in the absence of early and adequate management. The objective of this study was to evaluate cardiovascular risk in this population by comparing it with diabetic patients without fatty liver disease.Methods: We conclucted a cross-sectional study including 281 type 2 diabetics followed in Endocrino...

ea0063p1086 | Pituitary and Neuroendocrinology 3 | ECE2019

Predictive factors of surgical outcomes in acromegaly

Wafa Badr , Hasni Yosra , Chermiti Sondes , Abdelkarim Asma Ben , Kacem Maha , Chaieb Molka , Maaroufi Amel , Ach Koussay

Introduction: Acromegaly is a chronic disorder usually caused by growth hormone (GH)-secreting pituitary adenomas. Transsphenoidal surgery remains a treatment of choice for restoring GH to normal levels. The aim of this study was to illustrate the relationship between some factors and transsphenoidal surgery outcomes.Patients and methods: We retrospectively analysed the outcome of 31 patients with acromegaly after initial endoscopic transsphenoidal surge...

ea0056p87 | Clinical case reports - Pituitary/Adrenal | ECE2018

Long-term follow-up of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency

Elfekih Hamza , Hasni Yosra , Badr Wafa , Abdelkrim Asma Ben , Amor Bilel Ben , Maaroufi Amal , Kacem Maha , Chaieb Molka , Gribaa Moez , Ach Koussay , Saad Ali

Introduction: Congenital adrenal hyperplasia (CAH) due to an enzymatic defect in 11-beta-hydroxylase (11β-OHD) is the second most common cause of CAH representing 5-8% of cases. It is characterized by androgen excess, hypertension and hypokalemia. Here we describe the case of a patient having a CYP11B1 mutation and being followed-up during 33 years.Observation: A 36-year-old Tunisian male was diagnosed with 11β-OHD at the age of three years rev...